Clinical Trial Update: Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance [Phase 2]

View source ↗

Summary

This Phase 2 trial update describes a precision genomic strategy to assess mutation clearance in acute myeloid leukemia. The study is currently active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Washington University School of Medicine | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING